AIMC Topic: Genetic Testing

Clear Filters Showing 61 to 70 of 71 articles

EHR based Genetic Testing Knowledge Base (iGTKB) Development.

BMC medical informatics and decision making
BACKGROUND: The gap between a large growing number of genetic tests and a suboptimal clinical workflow of incorporating these tests into regular clinical practice poses barriers to effective reliance on advanced genetic technologies to improve qualit...

Multiple Testing of Gene Sets from Gene Ontology: Possibilities and Pitfalls.

Briefings in bioinformatics
The use of multiple testing procedures in the context of gene-set testing is an important but relatively underexposed topic. If a multiple testing method is used, this is usually a standard familywise error rate (FWER) or false discovery rate (FDR) c...

Prediction of core cancer genes using a hybrid of feature selection and machine learning methods.

Genetics and molecular research : GMR
Machine learning techniques are of great importance in the analysis of microarray expression data, and provide a systematic and promising way to predict core cancer genes. In this study, a hybrid strategy was introduced based on machine learning tech...

[Prophylactic surgery and genetic counselling: What impact of the artificial intelligence?].

Bulletin du cancer
In the area of cancer predisposition, certain situations may lead to the discussion of prophylactic surgery. This is rarely strictly recommended and depends on the patient's choice. The advantages and disadvantages must be weighed up. The main advant...

Could metabolic imaging and artificial intelligence provide a novel path to non-invasive aneuploidy assessments? A certain clinical need.

Reproduction, fertility, and development
Pre-implantation genetic testing for aneuploidy (PGT-A) via embryo biopsy helps in embryo selection by assessing embryo ploidy. However, clinical practice needs to consider the invasive nature of embryo biopsy, potential mosaicism, and inaccurate rep...

What Legal Frameworks Should Govern Use of Genetic Test Results by Private Health Insurers in New Zealand?

Journal of law and medicine
The rising cost of private health insurance and constraints within public health systems are global concerns. Genetic testing presents a transformative opportunity for health care to enhance health outcomes and optimise resource allocation through pe...

Validity of Natural Language Processing for Ascertainment of and Test Results in SEER Cases of Stage IV Non-Small-Cell Lung Cancer.

JCO clinical cancer informatics
PURPOSE: SEER registries do not report results of epidermal growth factor receptor () and anaplastic lymphoma kinase () mutation tests. To facilitate population-based research in molecularly defined subgroups of non-small-cell lung cancer (NSCLC), we...